Targeting B-cell receptor signalling using Bruton tyrosine kinase (BTK) inhibitors (BTKis) has
become a highly successful treatment modality for B-cell malignancies, especially for …

Despite the effectiveness of chemoimmunotherapy (CIT), in most cases the clinical course of
chronic lymphocytic leukemia (CLL) is characterized by consecutive episodes of disease …

Patients with hematologic malignancies are at increased risk of adverse COVID‐19
outcomes; nonetheless, only sparse population‐based data are available on mortality …

ABSTRACT Background Coronavirus disease 2019 (COVID-19), an acute, sometimes
severe respiratory illness caused by a novel coronavirus has led to a vast pandemic with an …

新型冠状病毒感染的肺炎(corona virus disease 2019, COVID-19) 疫情仍严重影响着世界各国
的医疗卫生体系, 而恶性肿瘤患者由于较低的免疫功能状态及更多的风险暴露, 影响更甚 …

Main aim of this systematic review is to quantify the risk and identify predictors of clinical
evolution of SARS‐CoV‐2 in hematological patients compared to different control …

Patients with chronic lymphocyticleukemia (CLL) typically have innate/adaptive immune
system dysregulation, thus the protective effect of coronavirus disease 2019 (COVID-19) …

Patients with hematologic malignancies are particularly vulnerable to infections due to
underlying humoral and cellular immune dysfunction, cytotoxic chemotherapy regimens …

Simple Summary The severe acute respiratory syndrome coronavirus (SARS-CoV-2) has
become the cause of a worldwide pandemic, and its clinical infection course in patients with …

Current evidence on chronic SARS-CoV-2 infection in immunocompromised populations is
reviewed including the relevance of this to the generation of novel variants. Continued viral …